Loading…
The initiative aims to advance robotic technology within the medical division.
NanoVibronix announced the official launch of a next-gen robotic development initiative within its ENvue Medical Division. The initiative focuses on enhancing robotic technology to improve medical procedures.
ENvue Medical, Inc. has a free float of 1,088,100 shares and 1,088,200 shares outstanding.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.